Anthony O. Okorodudu, PhD, DABCC
Telephone: (409) 772-3309 or 772-3197
Fax: (409) 772-9231
Department of Pathology
University of Texas Medical School
Galveston, TX 77555-0551
Faculty and Research Interests
|Adetoun Ejilemele, MBBS, DAACC, FABC||General clinical chemistry, Toxicology and TDM.|
|Karl E. Anderson, MD||Human porphyrias, especially the interaction of genetic and environmental factors and development of new treatments for these conditions|
|Anthony O. Okorodudu, PhD, MBA, DABCC, FACB||General clinical chemistry, Toxicology and TDM; Perturbation of intracellular cations in response to drugs/diseases; research and development to support introduction of new diagnostic systems|
|Michael Laposata, MD, PhD||Laboratory management, test utilization, (particularly as it relates to coagulation studies), identification of diagnostic errors and mechanisms to prevent them, and fatty acid biochemistry.|
|Peter McCaffrey, MD||Machine Learning, Artificial Intelligence, Biomedical Informatics, Computational Biology.|
Level(s) of training: Postdoctoral
Number of position available per year: 1
Duration of program: 2 years
Approximate annual salary or stipend: $56,000 (Consistent with PGY1)
Source of funding: Departmental
Current number of trainees: 1
Number of past graduates (over last 10 years): 10
PhD in natural sciences or MD, adequate education in biological chemistry at the graduate school level. If foreign degree, must pass advanced chemistry portion of the Graduate Record Examination (GRE).
Submit completed application form, curriculum vitae, statement of career goals, three letters of recommendation, and transcripts of graduate and undergraduate record. Interview required.
Apply by October 15 of the year preceding the July starting date.
The University of Texas Medical Branch in Galveston opened in 1891 as the nation’s first public medical school and hospital under unified leadership—already a pioneer. What began as one hospital and medical school building in Galveston is now a major academic health sciences center of global influence, with medical, nursing, health professions and graduate biomedical schools; a world-renowned research enterprise; and a growing, comprehensive health system with hospitals on four campuses and a network of clinics. Today, UTMB has a $3.3 billion annual statewide economic impact, in terms of business volume, personal income and durable goods purchases. More than 46,000 jobs in Texas are directly or indirectly attributed to UTMB. The health system has approximately 900 beds in all the campuses with full-service emergency rooms/trauma centers. Postdoctoral training in clinical chemistry will be entirely completed within the UTMB Health system. The patient population at UTMB is excellent with a full range of pediatric and adult medical and surgical cases.
Postdoctoral fellows will train with pathology residents. Responsibilities include seminars, selected medical lectures, journal club, selected topics in laboratory management, night call and clinical rounds. Management experience is incorporated into both years of training. Fellows also present lectures in selected topics, participate in the division’s director On-Call Service, and are assigned specific sections of the laboratory where they have technical responsibilities.
Special strengths of the UTMB program include scheduled didactic lectures, ward rounds, and scheduled rotation through all areas of the laboratory in the first six months, yearly in-service examinations, and use of state-of-the-art instrumentation. The fellows are also required to be involved in basic and applied research projects with focus in the areas of intracellular ions homeostasis, molecular toxicology, pharmacogenomics, and liver cancer.